Clinical Trials Logo

Clinical Trial Summary

Human cells are diploid (contain a double set of chromosomes). The diploid genome is complex and therefore limits genetic research approaches in biomedical models. To overcome this problem experimental generation of haploid stem cells has been done in animals. The investigators aim at generating haploid stem cells from human germ cells that are a useful tool in genetic research and screening.


Clinical Trial Description

Human cells are diploid (contain a double set of chromosomes). The diploid genome is complex and therefore limits genetic research approaches in biomedical models. To overcome this problem experimental generation of haploid stem cells has been done in animal models. haploid cells are easier for genetic manipulations, such as knock-in and knock-out of genes, and therefore should make a better experimental model. The investigators aim at generating haploid stem cells from human haploid germ cells. ;


Study Design

Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT01454765
Study type Observational
Source Rambam Health Care Campus
Contact
Status Recruiting
Phase N/A
Start date December 2011
Completion date August 2015

See also
  Status Clinical Trial Phase
Enrolling by invitation NCT05214742 - Developing Derived Induced Pluripotent Stem Cells as a Model to Understand Imprinted Disorders
Completed NCT01534624 - Stem Cell Study of Genetics and Drug Addiction
Withdrawn NCT02056613 - Blood Collection From Healthy Volunteers and Patients for the Production of Clinical Grade Induced Pluripotent Stem Cell (iPSC) Products